secwatch.observer — SEC 8-K summary
======================================

Issuer:     RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK:        0001649904
Form:       8-K
Filed at:   2024-02-29T23:59:59+00:00
Accession:  0001104659-24-029417
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rhythm Pharmaceuticals amends sales agreement to allow up to $200M in at-the-market stock offerings
--------------------------------------------------------------------------------

- Amendment increases ATM offering limit from $100M to $200M, excluding $50M already sold.
- Company had $50M in prior sales as of Feb 29, 2024; new capacity starts from zero.
- No specific use of proceeds disclosed; typical for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649904/000110465924029417/0001104659-24-029417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649904/000110465924029417/tm247530d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-029417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer